Buy Capnat 500mg Tablets | Buy Capecitabine Online | 印度希罗达价格 PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: Buy Capnat 500mg Tablets | Buy Capecitabine Online | 印度希罗达价格


1
Capecitabine Tablets
Anti-Cancer Medication
  • Capnat 500mg

www.MedsDelta.com
2
Capecitabine is an chemotherapy medication sold
under the brand name Xeloda. Capecitabine used to
treat Breast Cancer, Gastric Cancer and
Colorectal Cancer. Capecitabine was patented in
1992 and approved for medical use in 1998.
What is Capecitabine ?
www.MedsDelta.com
www.MedsDelta.com
3
Section Title 2
Capecitabine Uses
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Subtitle

www.MedsDelta.com
3
4
Section Title 2
Capnat Tablets Details
  • Capecitabine is available in strength of Capnat
    500mg Tablet and its active ingredients is
    Capecitabine 500mg.
  • Available in from of Tablets and Its packaging
    size is 10 tablets per strip.
  • Capnat Capecitabine Tablets is manufactured by
    Natco Pharma Ltd.
  • Subtitle

www.MedsDelta.com
4
5
Capnat 500mg Substitutes
Capcel 500mg
Xeloda 500mg
Capezam 500mg
www.MedsDelta.com
6
How To Take
How its Work
Capnat 500mg Tablet is a chemotherapy drug which
belongs to the class of Cytotoxic Antimetabolite.
It is orally taken and is changed over to
5-fluorouracil inside the cancer cells growth.
Capnat 500mg Tablet slows the growth of cancer
cells and slowly kills them. 
  • Capnat is a tablet so it is taken orally, swallow
    whole tablet with water. Take after food with
    water and doses as per your doctor prescribed.
    Dont chew, crush, or split the tablet before
    taking it and not mix with food and liquid.

www.MedsDelta.com
6
7
Common Side Effects
  • Headache
  • Weakness
  • Rashes
  • Itching
  • Vomiting
  • Fatigue
  • Hair loss
  • Abdominal Pain
  • Dry mouth

www.MedsDelta.com
8
Contact Us
Scan for WeChat WeChat MedsDelta QQ
3451266709 91-9971646666 medsdelta_at_gmail.com www
.MedsDelta.com
www.MedsDelta.com
Write a Comment
User Comments (0)